SEARCH

SEARCH BY CITATION

REFERENCES

  • Agergaard P, Olesen C, Østergaard JR, Christiansen M, Sørensen KM. 2012. The prevalence of chromosome 22q11.2 deletions in 2,478 children with cardiovascular malformations. A population-based study. Am J Med Genet Part A 158A:498508.
  • Antshel KM, Fremont W, Roizen NJ, Shprintzen R, Higgins AM, Dhamoon A, Kates WR. 2006. ADHD, major depressive disorder, and simple phobia are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 45(5):596603.
  • Atallah J, Joffe AR, Robertson CM, Leonard N, Blakley PM, Nettel-Aguirre A, Sauve RS, Ross DB, Rebeyka IM. 2007. Two-year general and neurodevelopmental outcome after neonatal complex cardiac surgery in patients with deletion 22q11.2: A comparative study. J Thorac Cardiovasc Surg 134(3):772779.
  • Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. 2003. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 160(9):15801586.
  • Bearden CE, Woodin MF, Wang PP, Moss E, McDonald-McGinn D, Zackai E, Emanuel B, Cannon TD. 2001. The Neurocognitive phenotype of the 22q11.2 deletion syndrome: Selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 23(4):447464.
  • Bellinger DC, Wypij D, Kuban KC, Rappaport LA, Hickey PR, Wernovsky G, Jonas RA, Newburger JW. 1999. Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation 100(5):526532.
  • Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM. 2003. A population-based study of the 22q11. 2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112(1):101107.
  • Carotti A, Digilio MC, Piacentini G, Saffirio C, Di Donato RM, Marino B. 2008. Cardiac defects and results of cardiac surgery in 22q11. 2 deletion syndrome. Dev Disabil Res Rev 14(1):3542.
  • Cheung EN, George SR, Andrade DM, Chow EW, Silversides CK, Bassett AS. 2013. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med [Epub ahead of print] DOI: 10.1038/gim.2013.71
  • De Smedt B, Devriendt K, Fryns J-P, Vogels A, Gewillig M, Swillen A. 2007. Intellectual abilities in a large sample of children with Velo–Cardio–Facial syndrome: An update. J Intellect Disabil Res 51(9):666670.
  • Devriendt K, Fryns J-P, Mortier G, Van Thienen MN, Keymolen K. 1998. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35(9):789790.
  • DiGeorge AM. 1965. Discussions on a new concept of the cellular basis of immunology. J Pediatr 67:907.
  • Driscoll DA, Budarf ML, Emanuel BS. 1992. A genetic etiology for DiGeorge syndrome: Consistent deletions and microdeletions of 22q11. Am J Hum Genet 50(5):924933.
  • Fabbro A, Rizzi E, Schneider M, Debbane M, Eliez S. 2012. Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). Eur Child Adolesc Psychiatry 21(7):379385.
  • Fallon P, Aparicio JM, Elliott MJ, Kirkham FJ. 1995. Incidence of neurological complications of surgery for congenital heart disease. Arch Dis Child 72(5):418422.
  • First MB, Gibbon M. 2004. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In: Hilsenroth MJ, Segal DL, editors. Comprehensive handbook of psychological assessment. Vol. 2, Personality assessment. Hoboken, NJ: John Wiley and Sons. pp 134143.
  • Forbess JM, Visconti KJ, Hancock-Friesen C, Howe RC, Bellinger DC, Jonas RA. 2002. Neurodevelopmental outcome after congenital heart surgery: Results from an institutional registry. Circulation 106(12):I95102.
  • Gerdes M, Solot C, Wang PP, Moss E, LaRossa D, Randall P, Goldmuntz E, Clark BJ, Driscoll DA, Jawad A, Emanuel BS, McDonald-McGinn DM, Batshaw ML, Zackai EH. 1999. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85(2):127133.
  • Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. 2010. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 122(22):22542263.
  • Glauser TA, Rorke LB, Weinberg PM, Clancy RR. 1990. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics 85(6):984990.
  • Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C, Conroy CG, Gur RC, Gur RE. 2012. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. Am J Med Genet B Neuropsychiatr Genet 159B(1):8793.
  • Golding-Kushner KJ, Weller G, Shprintzen RJ. 1984. Velo-cardio-facial syndrome: Language and psychological profiles. J Craniofac Genet Dev Biol 5(3):259266.
  • Gothelf D, Presburger Gadi D, Levy A, Nahmani M, Burg M, Berant L, Blieden Y, Finkelstein A, Frisch A, Apter A, Weizman A. 2004. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am J Med Genet B Neuropsychiatr Genet 126B:116121.
  • Gothelf D, Feinstein C, Thompson T, Gu E, Penniman L, Van Stone E, Kwon H, Eliez S, Reiss AL. 2007. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164(4):663669.
  • Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S. 2009. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48(11):10601068.
  • Gur RC, Richard J, Hughett P, Calkins ME, Macy L, Bilker WB, Brensinger C, Gur RE. 2010. A cognitive neuroscience based computerized battery for efficient measurement of individual differences: Standardization and initial construct validation. J Neurosci Methods 187(2):254262.
  • Gur RC, Richard J, Calkins ME, Chiavacci R, Hansen JA, Bilker WB, Loughead J, Connolly JJ, Qui H, Mentch FD, Abou-Sleiman PM, Hakonarson H, Gur RE. 2012. Age group and sex differences in performance on a computerized neurocognitive battery in children age 8–21. Neuropsychology 26(2):251265.
  • Hoffman JI, Kaplan S. 2002. The incidence of congenital heart disease. J Am Coll Cardiol 39(12):18901900.
  • Hoffman JI, Kaplan S, Liberthson RR. 2004. Prevalence of congenital heart disease. Am Heart J 147(3):425439.
  • Hooper SR, Curtiss K, Schoch K, Keshavan MS, Allen A, Shashi V. 2013. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. Res Dev Disabil 34(5):17581769.
  • Howley SA, Prasad SE, Pender NP, Murphy KC. 2012. Relationship between reaction time, fine motor control, and visual-spatial perception on vigilance and visual-motor tasks in 22q11.2 deletion syndrome. Res Dev Disabil 33(5):14951502.
  • Jolin EM, Weller RA, Jessani NR, Zackai EH, McDonald-McGinn DM, Weller EB. 2009. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome. J Affect Disord 119(1):177180.
  • Jolin EM, Weller RA, Weller EB. 2012. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11. 2 deletion syndrome. J Affect Disord 136(3):222228.
  • Karsdorp PA, Everaerd W, Kindt M, Mulder BJ. 2007. Psychological and cognitive functioning in children and adolescents with congenital heart disease: A meta-analysis. J Pediatr Psychol 32(5):527541.
  • Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryna N. 1997. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980988.
  • Kiley-Brabeck K, Sobin C. 2006. Social skills and executive function deficits in children with the 22q11.2 deletion syndrome. Appl Neuropsychol 13(4):258268.
  • Kovacs AH, Saidi AS, Kuhl EA, Sears SF, Silversides C, Harrison JL, Ong L, Colman J, Oechslin E, Nolan RP. 2009. Depression and anxiety in adult congenital heart disease: Predictors and prevalence. Int J Cardiol 137:158164.
  • Maharasingam M, Ostman-Smith I, Pike MG. 2003. A cohort study of neurodevelopmental outcome in children with DiGeorge syndrome following cardiac surgery. Arch Dis Child 88(1):6164.
  • Marino B, Digilio MC, Toscano A, Giannotti A, Dallapiccola B. 1999. Congenital heart defects in patients with DiGeorge/velocardiofacial syndrome and del22q11. Genet Couns 10(1):2533.
  • Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor J, Mussatto KA, Uzark K, Goldberg CS, Johnson WH, Li J, Smith SE, Bellinger DC, Mahle WT. 2012. Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management: A scientific statement from the American Heart Association. Circulation 126:11431172.
  • McDonald-McGinn DM, Sullivan KE. 2011. Chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome/Velocardiofacial syndrome). Medicine 90(1):118.
  • Miller G, Eggli KD, Contant C, Baylen BG, Myers JL. 1995. Postoperative neurologic complications after open heart surgery on young infants. Arch Pediatr Adolesc Med 149(7):764768.
  • Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. 2003. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29(4):703715.
  • Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10):940945.
  • Niklasson L, Rasmussen P, Oskarsdóttir S, Gillberg C. 2005. Attention deficits in children with 22q.11 deletion syndrome. Dev Med Child Neurol 47(12):803807.
  • Niklasson L, Rasmussen P, Oskarsdóttir S, Gillberg C. 2009. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 30(4):763773.
  • Ousley O, Rockers K, Dell ML, Coleman K, Cubells JF. 2007. A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: Implications for clinical evaluation and treatment. Curr Psychiatry Rep 9(2):148158.
  • Rogers BT, Msall ME, Buck GM, Lyon NR, Norris MK, Roland JM, Gingell RL, Cleveland DC, Pieroni DR. 1995. Neurodevelopmental outcome of infants with hypoplastic left heart syndrome. J Pediatr 126(3):496498.
  • Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Bruenton L, Brøndum-Nielsen K, Scambler PJ. 1997. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34(10):798804.
  • Schaer M, Glaser B, Cuadra MB, Debbane M, Thiran JP, Eliez S. 2009. Congenital heart disease affects local gyrification in 22q11.2 deletion syndrome. Dev Med Child Neurol 51(9):746753.
  • Schaer M, Glaser B, Ottet MC, Schneider M, Bach Cuadra M, Debbane M, Thiran JP, Eliez S. 2010. Regional cortical volumes and congenital heart disease: A MRI study in 22q11.2 deletion syndrome. J Neurodev Disord 2(4):224234.
  • Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. 2008. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 121(4):e759e767.
  • Spijkerboer AW, Utens EM, Bogers AJ, Helbing WA, Verhulst FC. 2008. A historical comparison of long-term behavioral and emotional outcomes in children and adolescents after invasive treatment for congenital heart disease. J Pediatr Surg 43:534539.
  • Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. 2010. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res 118(1):118121.
  • Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, Fryns JP. 1999. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): From infancy to adolescence. Genet Couns 10(1):7988.
  • Swillen A, Feys H, Adriaens T, Nelissen L, Mertens L, Gewillig M, Devriendt K, Fryns JP. 2005. Early motor development in young children with 22q. 11 deletion syndrome and a conotruncal heart defect. Dev Med Child Neurol 47(12):797802.
  • Tang SX, Yi JJ, Calkins ME, Whinna DA, Kohler CG, Souders MC, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. 2013. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but under-treated. Psychol Med 9:111.
  • Van Aken K, De Smedt B, Van Roie A, Gewillig M, Devriendt K, Fryns JP, Simons J, Swillen A. 2007. Motor development in school-age children with 22q11 deletion (velocardiofacial.D iGeorge syndrome). Dev Med Child Neurol 49:210213.
  • Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H. 2006. The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45(9):11041113.
  • Wernovsky G, Shillingford AJ, Gaynor JW. 2005. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol 20(2):9499.
  • Wilkinson GS, Robertson GJ. 2006. Wide range achievement test. 4th edition. Lutz, FL: Psychological Assessment Resources WRAT 4 Introductory Kit.